Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Trilavir L Tablet
Manufacturer/Marketed By : LAURUS LABS LTD
$37.93 $28.46
Trilavir L tablet contains the active substance called Efavirenz, Lamivudine, Tenofovir Disoproxil Fumarate. Efavirenz is an antiretroviral family in the class of medications called nonnucleoside reverse transcriptase inhibitors (NNRTIs). Whereas,...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
EFAVIRENZ,LAMIVUDINE,TENOFOVIR DISOPROXIL FUMARATE
Active Pharmaceutical Ingredient
Trilavir L Tablet
37,93$
28,46$
Trilavir L tablet contains the active substance called Efavirenz, Lamivudine, Tenofovir Disoproxil Fumarate. Efavirenz is an antiretroviral family in the class of medications called nonnucleoside reverse transcriptase inhibitors (NNRTIs). Whereas, Lamivudine and Tenofovir Disoproxil Fumarate is an antiretroviral or Anti-Viral medicine belonging to the class of medications called nucleotide reverse transcriptase inhibitors (NRTI). Do not take Trilavir L tablet if you are allergic to Efavirenz, Lamivudine, Tenofovir Disoproxil Fumarate, or its other medical ingredients. Patients diagnosed with pancreatitis or at risk of pancreatitis should take this combination of medicine cautiously. During this treatment, your doctor may periodically monitor your blood counts, bone mineral density, and liver and kidney parameters to prevent serious complications. Report to your doctor if you have or had a history of heart failure (QT prolongation), seizures, mental health issues, pancreatitis (inflammation in the pancreas), bone disease (osteonecrosis - the death of bone tissue), fractures, liver (chronic hepatitis B or C), or kidney problems. Inform your doctor if you are planning to get pregnant or think you may be pregnant. Breastfeeding is not recommended while taking Trilavir L tablet, due to the potential transmission of HIV from the mother to the baby.
Active Pharmaceutical Ingredient
Uses
• Treatment of HIV infections
Benefits
The reverse transcriptase enzyme produces copies of the DNA of HIV. Lamivudine and Tenofovir are Nucleoside reverse transcriptase inhibitors. Efavirenz is a Nonnucleoside Reverse Transcriptase Inhibitor that directly inhibits the enzyme reverse transcriptase. This blocks the replication and reproduction of the virus.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Most Common Side Effects
• Bloating, flatulence
• Headache
• Sleeplessness
• Skin reactions
• Wheezing, swelling, or lightheadedness
• Hair loss
• Diarrhea
• Bone disorders
• Weakness
• Anemia
Common Side Effects
• Rapid breathing
• Drowsiness
• Nausea, vomiting, and stomach pain
• Severe allergic reactions
• Severe mood disturbances, depression, and suicidal thoughts
• Confusion, forgetfulness, seizures, and tremor
• Liver toxicity
• Kidney damage
• Autoimmune disorders
How To Use
It is an orally available prescription drug. Your doctor will decide the dose and duration of Trilavir L tablet based on the disease condition and other factors. Always take this medicine as prescribed by your doctor. Take the tablet at the same time. Do not take an additional dose to compensate for the missed dose.
Safety Advice
• Breast Feeding: It is unsafe to breastfeed if you are with HIV infection. Consult your doctor for more information about Trilavir L tablet.
• Alcohol: Do not consume alcohol while taking the Trilavir L tablet, as this injection may cause drowsiness with alcohol
• Liver: Inform your physician about any underlying liver disorders before taking Trilavir L tablet should be used cautiously in liver disease patients. Your doctor may monitor your liver enzymes. Consult your physician before taking this medicine.
• Lungs: It is unknown whether Trilavir L tablet is safe for patients with lung problems. Inform your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.
• Driving: It is unsafe to drive while taking Trilavir L tablet because this medicine might cause vision problems and tiredness, so avoid driving and operating machinery during this treatment.
• Pregnancy: Notify your healthcare professional if you are pregnant or planning to have a baby think you may be pregnant. Your physician will conduct regular tests to monitor the development of your child. Ask for suggestions before taking the Trilavir L tablet.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.